134 related articles for article (PubMed ID: 2744332)
1. Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitis.
Karino Y; Sugawara T; Saga A; Yoshida J; Matsushima T; Miyazaki T; Toyota J; Okuuchi Y
Gastroenterol Jpn; 1989 Apr; 24(2):164-9. PubMed ID: 2744332
[TBL] [Abstract][Full Text] [Related]
2. [2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells obtained from patients with chronic hepatitis B during interferon therapy].
Sugawara T
Hokkaido Igaku Zasshi; 1990 Sep; 65(5):439-54. PubMed ID: 2227795
[TBL] [Abstract][Full Text] [Related]
3. Activities of 2'-5'oligoadenylate synthetase in peripheral blood mononuclear cells of patients with viral hepatitis, and chronic type B hepatitis during interferon therapy.
Sugawara T; Matsushima T; Miyazaki T; Toyota J; Fujii N; Minagawa T
Jpn J Med; 1986 May; 25(2):144-8. PubMed ID: 3747259
[TBL] [Abstract][Full Text] [Related]
4. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
Karino Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
[TBL] [Abstract][Full Text] [Related]
6. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance].
Komiyama T; Akaike M; Satomura K; Okumura H
Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348
[TBL] [Abstract][Full Text] [Related]
7. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
Hirai N; Shimizu M; Morioka T; Hinoue Y; Tanaka N; Kobayashi K; Hattori N; Hashimoto T
Liver; 1988 Jun; 8(3):138-45. PubMed ID: 3393063
[TBL] [Abstract][Full Text] [Related]
8. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
Daito K; Suou T; Kawasaki H
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):303-16. PubMed ID: 8008980
[TBL] [Abstract][Full Text] [Related]
9. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.
Kim KI; Kim SR; Sasase N; Taniguchi M; Harada S; Kinoshita K; Kim SH; Akimoto Y; Shikata M; Kimura N; Izawa S; Ohtani A; Nakao K; Motojima M; Kinoshita M; Hirai M; Ohzu M; Hirooka T; Nabeshima S; Ishii F; Tanaka K; Hotta H
J Clin Pharm Ther; 2006 Oct; 31(5):441-6. PubMed ID: 16958821
[TBL] [Abstract][Full Text] [Related]
10. Significance of 2',5'-oligoadenylate synthetase activity and HCV genotype in IFN therapy for type C chronic hepatitis.
Karino Y; Hige S; Matsushima T; Miyazaki T; Toyota J
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1354-9. PubMed ID: 7705748
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G
J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
Mizukoshi E; Kaneko S; Kaji K; Terasaki S; Matsushita E; Muraguchi M; Ohmoto Y; Kobayashi K
Hepatology; 1999 Nov; 30(5):1325-31. PubMed ID: 10534358
[TBL] [Abstract][Full Text] [Related]
13. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
[TBL] [Abstract][Full Text] [Related]
14. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon.
Nakajima S; Kuroki T; Shintani M; Kurai O; Takeda T; Nishiguchi S; Shiomi S; Seki S; Kobayashi K
Hepatology; 1990 Dec; 12(6):1261-5. PubMed ID: 2147916
[TBL] [Abstract][Full Text] [Related]
15. 2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.
Giannelli G; Antonelli G; Fera G; Dianzani F; Schiraldi O
J Interferon Res; 1993 Feb; 13(1):57-60. PubMed ID: 8454912
[TBL] [Abstract][Full Text] [Related]
16. [2'-5' olygoadenylate synthetase activity in peripheral facial paralysis].
Nakazato H; Ikeda M
Nihon Jibiinkoka Gakkai Kaiho; 1995 Mar; 98(3):457-64. PubMed ID: 7738709
[TBL] [Abstract][Full Text] [Related]
17. 2',5' Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis.
Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
Gastroenterol Jpn; 1991 Oct; 26(5):603-10. PubMed ID: 1752391
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
[TBL] [Abstract][Full Text] [Related]
19. Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2',5'oligoadenylate system and clinical response.
de Mel WC; Hoffbrand AV; Giles FJ; Goldstone AH; Mehta AB; Ganeshaguru K
Br J Haematol; 1990 Apr; 74(4):452-6. PubMed ID: 2346724
[TBL] [Abstract][Full Text] [Related]
20. The sequential change of serum 2',5' oligoadenylate synthetase in different infectious patterns of duck hepatitis B virus in ducks in experimental transmission.
Akagi S; Fukuda R; Shimada Y
Gastroenterol Jpn; 1992 Jun; 27(3):374-81. PubMed ID: 1378031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
